Sign Up to like & get
recommendations!
0
Published in 2024 at "ACS medicinal chemistry letters"
DOI: 10.1021/acsmedchemlett.3c00461
Abstract: Cannabidiol (CBD 1) is a nonpsychotic cannabinoid-based drug approved by the U.S. FDA for treating refractory epilepsy, namely, Lennox-Gastaut and Dravet syndrome. However, its low aqueous solubility and oral bioavailability are compensated by administering high…
read more here.
Keywords:
synthesis bioevaluation;
cannabidiol based;
cbd based;
based prodrugs ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Pharmaceuticals"
DOI: 10.3390/ph18050755
Abstract: Background/Objectives: Cannabidiol (CBD) has been reported for its antinociceptive, anti-inflammatory, and neuroprotective activities. However, several legal restrictions on its medicinal uses and even research have contributed to the development of synthetic analogues. Therefore, the aim…
read more here.
Keywords:
cbd based;
pqm;
acyl hydrazone;
terpene cinnamoyl ... See more keywords